Hemant Prashad Sharma, MD

Hemant Sharma, MD, MHS, is the Chief of the Division of Allergy and Immunology at Children’s National. He is an Associate Professor of Pediatrics at George Washington University School of Medicine, and the Director of the Food Allergy Program at Children’s National. He has served as the site director of the allergy immunology fellowship program with the National Institutes of Health. He is Director of the FARE (Food Allergy Research & Education) Clinical Network site at Children’s National.

Dr. Sharma completed medical school at Columbia University College of Physicians and Surgeons, residency and chief residency at Duke University and pediatric allergy and immunology fellowship at Johns Hopkins. During fellowship, he completed a Masters in Clinical Epidemiology at the Johns Hopkins Bloomberg School of Public Health, as well as a fellowship in Health Media at Nemours.

He joined the faculty at Children’s National in 2008. His areas of clinical, advocacy and research interest include racial and socioeconomic health disparities and community-based management of food allergy. He writes a quarterly column in Allergic Living magazine and answers readers’ food allergy questions. He is heavily involved in advocacy, participating in regional and national legislative efforts to improve the health of the food allergy community. Dr. Sharma is board-certified in Pediatrics and in Allergy and Immunology, and is a fellow of the American Academy of Allergy, Asthma and Immunology, serving on the Adverse Reactions to Foods Committee. Due to his efforts on behalf of the food allergy community, he was selected to receive the 2016 FARE Vision Award.

• Allergy and Immunology
• Cancer and Blood Disorders Center

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

• Novartis
• Mylan Specialty L.P.
• Merck Sharp & Dohme